Aligos Therapeutics Inc. (ALGS) Misses Q2 EPS by 153c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics Inc. (NASDAQ: ALGS) reported Q2 EPS of ($1.53).
For earnings history and earnings-related data on Aligos Therapeutics Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- DA Davidson Starts Armstrong World Industries (AWI) at Neutral
- Supreme Court lifts decision that blocked in 23 states and Washington, D.C. Trump's order restricting mail-in ballots
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
